Literature DB >> 27551405

Accounting for multimorbidity can affect the estimation of the Burden of Disease: a comparison of approaches.

Henk B M Hilderink1, Marjanne H D Plasmans1, Bianca E P Snijders1, Hendriek C Boshuizen2, M J J C René Poos1, Coen H van Gool1.   

Abstract

BACKGROUND: Various Burden of Disease (BoD) studies do not account for multimorbidity in their BoD estimates. Ignoring multimorbidity can lead to inaccuracies in BoD estimations, particularly in ageing populations that include large proportions of persons with two or more health conditions. The objective of this study is to improve BoD estimates for the Netherlands by accounting for multimorbidity. For this purpose, we analyzed different methods for 1) estimating the prevalence of multimorbidity and 2) deriving Disability Weights (DWs) for multimorbidity by using existing data on single health conditions.
METHODS: We included 25 health conditions from the Dutch Burden of Disease study that have a high rate of prevalence and that make a large contribution to the total number of Years Lived with a Disability (YLD). First, we analyzed four methods for estimating the prevalence of multimorbid conditions (i.e. independent, independent age- and sex-specific, dependent, and dependent sex- and age-specific). Secondly, we analyzed three methods for calculating the Combined Disability Weights (CDWs) associated with multimorbid conditions (i.e. additive, multiplicative and maximum limit). A combination of these two approaches was used to recalculate the number of YLDs, which is a component of the Disability-Adjusted Life Years (DALY).
RESULTS: This study shows that the YLD estimates for 25 health conditions calculated using the multiplicative method for Combined Disability Weights are 5 % lower, and 14 % lower when using the maximum limit method, than when calculated using the additive method. Adjusting for sex- and age-specific dependent co-occurrence of health conditions reduces the number of YLDs by 10 % for the multiplicative method and by 26 % for the maximum limit method. The adjustment is higher for health conditions with a higher prevalence in old age, like heart failure (up to 43 %) and coronary heart diseases (up to 33 %). Health conditions with a high prevalence in middle age, such as anxiety disorders, have a moderate adjustment (up to 13 %).
CONCLUSIONS: We conclude that BoD calculations that do not account for multimorbidity can result in an overestimation of the actual BoD. This may affect public health policy strategies that focus on single health conditions if the underlying cost-effectiveness analysis overestimates the intended effects. The methodology used in this study could be further refined to provide greater insight into co-occurrence and the possible consequences of multimorbid conditions in terms of disability for particular combinations of health conditions.

Entities:  

Keywords:  Disability weights; Disease burden; Multimorbidity; Prevalence

Year:  2016        PMID: 27551405      PMCID: PMC4993005          DOI: 10.1186/s13690-016-0147-7

Source DB:  PubMed          Journal:  Arch Public Health        ISSN: 0778-7367


Background

The Disability-Adjusted Life Year (DALY) is a widely used measure to quantify the burden of disease (BoD) in a population and to prioritize public health policy [1]. The DALY factors in premature mortality as expressed in Years of Life Lost (YLLs), and loss of quality of life due to suboptimal health status as expressed in Years Lived with a Disability (YLDs). The latter measure indicates the morbidity level, combining the occurrence of health conditions and their severity as represented by the Disability Weight (DW) [2, 3]. YLD calculations are based on a prevalence perspective, which is considered an adequate measurement of the level of disability experienced in a particular population at a particular moment in time [4]. The incidence perspective, on the other hand, combines the incidence of a particular event and its duration, and provides a measure of the loss of health connected with events in a given time period [Schroeder 2012]. Ignoring multimorbidity (i.e. co-occurrence of multiple health conditions within one person [5]), as has been done in various BoD studies so far, might result in overestimation of the number of YLDs and therefore overestimation of the overall disease burden [6, 7]. Also in Dutch studies, YLD calculations do not account for multimorbidity; for example, those included in the latest Public Health Status and Forecasts (PHSF) report [8]. This same publication, however, did recognize the importance of multimorbidity, reporting that in 2011, 1.9 million persons had two or more health conditions, representing 11 % of the Dutch population, with a projected increase to 3 million persons or 17 % by 2030. Multimorbidity occurs more often at older ages than at younger ages. Correcting for multimorbidity is therefore relevant to support policy intervention strategies, especially those aimed at an ageing population. Accounting for multimorbidity in BoD studies requires not only estimates of the prevalence of multimorbid conditions, but also estimates of the severity of (two or more) health conditions [6]. Existing studies on the prevalence of multimorbid conditions are limited to combinations of two health conditions [9]. The Disability Weights associated with multimorbid conditions can be determined by means of a direct population sample, but this method is costly and time-consuming. Alternative approaches have been developed that derive the Disability Weights associated with multimorbid conditions from the underlying single health conditions. The three most frequently used methods are the additive, multiplicative and maximum limit methods [6, 10–13]. To date, there is a lack of studies providing insight into the possible effects on the disease burden of combining the approaches for determining the prevalence of multimorbid conditions and the associated Disability Weights. The objective of this study is to apply different methods for estimating the prevalence of multimorbidity and estimating the Disability Weights associated with multimorbid conditions. In addition, we analyzed the effects that combining these methods would have on the number of YLDs. This analysis was performed using existing data concerning the prevalence of 25 selected health conditions in the Netherlands.

Methods

In this context, multimorbidity is defined as the co-occurrence of multiple chronic or acute diseases and medical conditions within one person [5]. To take multimorbidity into account, various methods have been included in the analysis (see Fig. 1). These methods apply to the prevalence of multimorbidity (Fig. 1, left) as well as the Combined Disability Weights (CDWs) (Fig. 1, right). We included four methods for estimating the prevalence of multimorbidity and three methods for determining Combined Disability Weights, resulting in 12 variants for calculating the effect of multimorbidity on the BoD. As a reference for these variants, we used the approach applied in the PHSF report [7], which actually is one of the variants.
Fig. 1

Various methodologies to account for multimorbidity prevalence and Disability Weights

Various methodologies to account for multimorbidity prevalence and Disability Weights

Data and selection of health conditions

The data used to analyze multimorbidity consist of the data on the prevalence of health conditions and Disability Weights as published in the Dutch Public Health Status and Forecasts report (PHSF, [8]). The health conditions reported in the PHSF are considered the most relevant conditions in the Netherlands in terms of mortality, prevalence, cost, and impact on individuals and society [14]. Prevalence data for the health conditions have been derived from sources including GP registration databases and the Netherlands Cancer Registry, and are available by sex and for 5-year age cohorts, with persons over the age of 85 as the last age cohort. Disability weights were assigned to these health conditions based on the findings of the Dutch Disability Weights Study [15]. We have selected 25 health conditions for analysis, based on the following criteria: 1) high prevalence, 2) large contribution to the YLD component of the disease burden, and 3) variation in types (both mental and physical) (Table 1).
Table 1

Overview of the 25 health conditions included in the analysis: prevalence, Disability Weight (DW), Years Lived with a Disability (YLD), and Disability-Adjusted Life Years (DALY), 2011 [34]

PrevalenceDWYLDDALY
Arthrosis7.12 %0.103122,423123,509
Anxiety disorders5.77 %0.187180,220180,272
Diabetes mellitus5.00 %0.198165,150194,312
Hearing disorders4.86 %0.10988,34488,344
Mood disorders2.31 %0.425164,025164,592
Neck and back pain3.91 %0.236153,930154,499
Coronary heart disease3.62 %0.288174,090282,834
Asthma2.86 %0.08038,19239,244
COPD2.17 %0.314113,600177,809
Contact eczema1.94 %0.07022,72022,720
Visual impairments1.81 %0.13741,34841,375
Cardiac arrhythmias1.17 %0.15430,14248,305
Stroke1.11 %0.609113,147191,320
Breast cancer0.60 %0.26526,45988,019
Heart failure0.85 %0.15421,80967,660
Intellectual disabilities0.77 %0.43055,59956,929
Personality disorders0.60 %0.27327,43827,438
Colon cancer0.36 %0.29417,66787,177
Prostate cancer0.40 %0.23115,27139,403
Dementia0.48 %0.67854,744112,130
Valve problems0.46 %0.118909128,346
Skin cancer0.24 %0.070276819,446
Lung cancer0.12 %0.2855845169,120
Parkinson’s disease0.19 %0.49715,40125,657
Non-Hodgkin’s lymphoma0.13 %0.233491020,749
Overview of the 25 health conditions included in the analysis: prevalence, Disability Weight (DW), Years Lived with a Disability (YLD), and Disability-Adjusted Life Years (DALY), 2011 [34]

Different approaches to estimating the prevalence of multimorbidity

Various methods are used to calculate the prevalence of combinations of health conditions, based on existing data on the prevalence of single health conditions (Fig. 1): In Method A and C, health conditions are considered independently, as assumed in the GBD studies for 2010 and 2013 [3, 16]. This means that the occurrence of one health condition is assumed to have no effect on the occurrence of another health condition. In Method A, the calculations are performed for the entire population (non-age-specific and non-sex-specific). In Method C, calculations are stratified by gender and by 5-year age cohort. In Method B and D, the occurrence of health conditions is assumed to be interdependent. This is taken into account in the calculations by applying a dependence correction factor. In this study, dependence is only applied to combinations of two health conditions, due to a lack of insight into and data about combinations of more than two conditions. Combinations of more than two health conditions are regarded as occurring independently, as in Method A and C. Method B is applied to the entire population (non-age-specific and non-sex-specific). In Method D, the calculations are stratified by gender and by 5-year age cohort. Method A and C represent the most straightforward approach, and assume that health conditions occur independently. Suppose we have n health conditions and the probability of having health condition i is p for i in 1 … n. The probability of having both health conditions i and j is: The probability of having only two health conditions i and j, and no other health condition, is: For 25 health conditions, there are more than 33 million possible combinations. Calculating the prevalence of these combinations requires a great deal of computing capacity. However, when health conditions are assumed to occur independently, the probability of having more than five health conditions is very small (no more than 1.5 in a million). We therefore limited our analyses to combinations of no more than five health conditions out of a total of 25 health conditions, which resulted in 68,405 unique combinations. This approach disregards two important issues. Firstly, different health conditions may have shared risk factors (e.g. smoking not only increases the risk of a stroke but also of developing COPD). Secondly, some health conditions may increase the risk of getting another health condition, e.g. diabetes mellitus and cardiovascular diseases. As a result, some combinations of health conditions occur more frequently than might be expected if independence is assumed. Odds ratios (i.e. the ratio of the odds of the observed prevalence of two health conditions compared to the prevalence when independence is assumed) can be used to calculate the prevalence corrected for dependence. Van Oostrom et al. [17] published the odds ratios for nine health conditions (i.e. the ratio between observed and independent prevalence) in an older population. Only eight of these health conditions appear in our list of 25 health conditions. Since odds ratios for combinations of the 25 health conditions are not available, we used the median of the odds ratios reported by Van Oostrom et al. [17] (i.e. an odds ratio of 1.3). These odds ratios are only applied to combinations of two health conditions, since no data are currently available on odds ratios for combinations of more than two health conditions. This adjustment for interdependence between the prevalence of two health conditions is included in Method B and D. The ratio OR between the odds of the real prevalence p assuming interdependence between two health conditions i and j, and the odds of the prevalence assuming independence p between those two conditions may be calculated as follows: This formula can be rewritten as: When odds ratios are used, p is always between 0 and 1. When the odds ratios are known, p can be calculated for each combination of two health conditions. In all methods, these probabilities replace the probabilities of the occurrence of combinations of two health conditions based on independence. In order to keep the total probability of health condition i and j the same, the probability that people only have health condition i (p ') or j (p ') is adjusted as follows: and The probability p0 of having none of the n health conditions is adjusted as follows: Calculating the prevalence by gender and age may result in a lower prevalence for some combinations of health conditions compared to calculations for the population as a whole. For example, asthma is more prevalent among young people, and will therefore not occur as often in combination with old-age-related health conditions such as dementia. On the other hand, dementia will occur more often in combination with other chronic health conditions like arthrosis because of the age-related nature of these conditions.

Different approaches to Combined Disability Weights (CDWs)

To adjust the Disability Weights for multimorbidity, we applied three approaches: the additive approach (Method 1), the multiplicative approach (Method 2) – as assumed in the GBD studies for both 2010 and 2013 [3, 16] – and the maximum limit approach (Method 3). These three methods exclude the possibility that a combined multimorbidity effect in terms of disability can be higher than the sum of the underlying disabilities. At the individual level, there may be combinations that could result in so-called over-additivity. We have assumed that over-additivity is less relevant at population level, and have therefore not included it in our analysis. Method 1 (Fig. 1) represents an additive model in which the resulting impact of combined health conditions is defined as the sum of the impacts of the individual health conditions. It is assumed that the impact of each health condition is the same, regardless of the presence of other conditions. The Combined Disability Weight of health conditions i and j is therefore calculated as follows: where DW is the Disability Weight of health condition i, and DW is the Disability Weight of health condition j. Method 2 represents a multiplicative model in which each health condition proportionally contributes to the Combined Disability Weight. The Combined Disability Weight of health conditions i and j is therefore calculated as follows: In Method 3, the maximum limit approach ignores co-existing health conditions and assumes that the most serious condition “trumps” the others. The Combined Disability Weight of health conditions i and j is therefore calculated as follows:

Years Lived with a Disability (YLD)

The overall objective is to estimate the health loss that is associated with a specific health condition, as well as the overall health loss from all health conditions occurring in a population. The number of Years Lived with a Disability (YLD) for health condition i is considered from a prevalence perspective [4], and may be calculated as follows: And for the total population: where pis the prevalence of health condition i, DW is the corresponding Disability Weight, and n is the total number of health conditions occurring in a population. This calculation implicitly assumes that when a person has more than one health condition, the disabilities associated with these health conditions may be added up (Eq. 12). This assumption most likely results in an overestimation of the total number of YLDs in the population. In order to determine how much of the disability can be attributed to a specific health condition, the fraction of the Disability Weight (DWF) that is attributable to a specific health condition is calculated [18]. If a person has k different health conditions with corresponding Disability Weights DW1 … DW, the DWF attributable to health condition i may be calculated as follows: The attributable Disability Weight DWA caused by health condition i in this person may be calculated as follows: where DW1 …  is the Combined Disability Weight of health conditions 1 … k If these formulas are applied to the three different methods for calculating Combined Disability Weights, the results are as follows: Suppose t people in a population have health condition i. The YLDs attributable to health condition i in the entire population may be calculated as follows: where DWA is the attributable Disability Weight caused by health condition i in a person p. The analyses were performed using R version 3.1.0. The R-scripts are available upon request.

Results

Prevalence of multimorbidity

Figure 2 shows that, when independence is assumed between health conditions in the overall study population (i.e. applying Method A), almost 60 % of the population does not have any health condition, about 30 % has one of the selected health conditions, 8 % has two health conditions, and 3 % has three or more health conditions. When independence between health conditions is assumed in age- and sex-specific analyses (i.e. Method C), the results show that 35 % of the population has at least one health condition (Fig. 2). When Method B is applied and interdependence between different health conditions is assumed, the prevalence is slightly lower for single health conditions and slightly higher for double health conditions compared to the results produced by Method A.
Fig. 2

Prevalence of average number of health conditions in a person (determined using the four methods for calculating the prevalence of combinations of health conditions)

Prevalence of average number of health conditions in a person (determined using the four methods for calculating the prevalence of combinations of health conditions) Figure 3 shows the relative (left) and absolute (right) age- and sex-specific prevalence of the average number of health conditions in a person, determined in accordance with Method C. A clustering of health conditions occurs at higher ages (75 years and over). The proportion of the population without any health conditions is 10 % in the 75+ age cohort, and around 60 % has two or more health conditions. This age-specific pattern is similar for men and women in relative terms, although women outnumber men at higher ages in absolute terms, resulting in a higher contribution by women to the health condition burden (results included in Appendix).
Fig. 3

Relative (left) and absolute (right) prevalence of average number of health conditions in a person by age, determined using Method C

Relative (left) and absolute (right) prevalence of average number of health conditions in a person by age, determined using Method C Looking at specific health conditions, there is a distinct difference between total-population methods (Methods A and C) and sex- and age-specific methods (Methods B and D). Figure 4 shows the differences between Method A and Method C. Although the overall prevalence of health conditions displays a relatively wide range of variation (Table 1), the probability of occurrence of a single health condition either by itself or in combination with one or more of the other 24 health conditions shows little variation in Method A (Fig. 4, left). This can be explained by looking at the probability of not having any other health condition, which has a strong commonality for different health conditions. In Method C and D, the underlying age-specific variation in prevalence results in greater overall variation. Applying Method C (Fig. 4, right) shows that the vast majority of dementia cases (almost 90 %) occur in combination with another health condition, due to a clustering of chronic health conditions at higher ages. In contrast, anxiety disorders may be regarded as a health condition typical of middle age and co-occur with another health condition in only 30 % of cases, assuming independent occurrence.
Fig. 4

Total-population (Method A, left) and sex- and age-specific (Method C, right) calculated prevalence of average number of health conditions in a person, by health condition

Total-population (Method A, left) and sex- and age-specific (Method C, right) calculated prevalence of average number of health conditions in a person, by health condition

Three different methods for calculating Combined Disability Weights

The Disability Weights for the 25 selected health conditions range from 0.070 to 0.678 (Table 1). Figure 5 shows the distribution of Disability Weights when three different calculation methods are applied, for all possible combinations of health conditions. These combinations concern the simultaneous occurrence of one to five health conditions. When looking at a combination of five health conditions, the Combined Disability Weights range from 0.432 to 2.639 when the additive method is applied. By definition, the Disability Weight should not exceed 1 (which corresponds with death), although this may occur when the additive method is applied. When the multiplicative method is applied, the Disability Weights are lower and have a smaller range (0.364 - 0.979). Application of the maximum limit method results in even lower Disability Weights (0.109 - 0.678). In general, the maximum limit method (Method 3) results in the largest downward adjustment of the Combined Disability Weight (CDW) compared to the additive method. When the multiplicative method is applied, the resulting CDWs are higher than when Method 3 is applied, but lower than when Method 1 is applied (see Fig. 5).
Fig. 5

Box plot of the distribution of Disability Weights for the three methods for calculating Combined Disability Weights

Box plot of the distribution of Disability Weights for the three methods for calculating Combined Disability Weights

Impact of different methods for calculating prevalence and Disability Weight on YLD estimates

Combining the methods for calculating the prevalence of multimorbidity and the methods for calculating the Disability Weights of multimorbid conditions results in twelve disease burden outcomes for the selected 25 conditions, expressed in YLDs (Fig. 6). The YLDs calculated using Method A (no sex or age specificity) in combination with Method 1 (additive method) actually correspond to not taking multimorbidity into account, and amount to a total of 1.72 million years lived with disability for the 25 selected health conditions. This combination serves as a reference for the other eleven combinations. Calculating YLDs based on the assumption of independent prevalence (Method A) in combination with the multiplicative approach (Method 2) for combining Disability Weights – which corresponds to the perspective of the GBD studies [3, 16] – yields 1.64 million years lived with a disability. This corresponds to a downward adjustment of 4.6 % compared to not taking multimorbidity into account. Calculating the sex- and age-specific prevalence assuming interdependence (Method D) in combination with the maximum limit method (Method 3) results in the largest downward YLD adjustment, by 26 % to a level of 1.28 million years lived with a disability. The YLD adjustment when the multiplicative method (Method 2) is used, amounts to 10 % for sex- and age-specific prevalence (Method D).
Fig. 6

YLD estimates determined using the methods for estimating prevalence and Disability Weights

YLD estimates determined using the methods for estimating prevalence and Disability Weights Looking at specific health conditions, anxiety disorders are associated with a moderate adjustment of the related-disease burden (up to 13 %, Fig. 7), because of a relative high prevalence in middle age (25–45 years). The health conditions that are associated with a high adjustment, such as coronary heart disease (up to 33 %) and heart failure (up to 43 %), all show a strong increase in prevalence with age.
Fig. 7

YLD estimates for anxiety disorders and coronary heart disease, determined using the different methods

YLD estimates for anxiety disorders and coronary heart disease, determined using the different methods The Appendix includes a table that provides the results for all twelve methods, for all 25 selected health conditions.

Discussion

A key focus area in multimorbidity research is the development of tools to explore multimorbidity and its impact on, for example, burden of disease, disability and quality of life [19]. Various Burden of Disease (BoD) studies do not account for multimorbidity in their BoD estimates. In this study, we applied four different methods to estimate the prevalence of multimorbidity, and three different methods to calculate the Disability Weights associated with multimorbid conditions. This resulted in twelve different calculations of the number of Years Lived with a Disability (YLDs), in order to analyze the impact of multimorbidity on BoD estimates in the Netherlands. We found that multimorbidity adjustments can have a substantial impact on YLD estimates for the 25 health conditions included in our analysis. When a multiplicative method is applied to determine Combined Disability Weights, the YLDs are 5 % lower than when the additive method is used, and 14 % lower than when the maximum limit method is used. Adjusting for the sex- and age-specific dependent co-occurrence of health conditions reduces YLD estimates by 10 % when the multiplicative method is used, and by 26 % when the maximum limit method is used. Considering the four different methods for estimating the prevalence of multimorbidity, we found the highest level of clustering of health conditions in the sex- and age-specific calculation (Methods C and D), i.e. a relatively high occurrence of multimorbidity. Some studies have estimated the overall prevalence of multimorbidity in both the general population and in primary care settings, leading to marked variations among studies with respect to both methodology and findings [20-22]. Based on an analysis of registration data for 29 health conditions, Van Oostrom et al. [17] found that 17 % of primary care patients in the Netherlands are disease-free and 59 % have two or more health conditions [17]. When looking at specific clusters of health conditions, our approach to estimating the prevalence of multimorbidity resulted in a stronger correlation between health conditions that progress with age, such as dementia and cardiovascular diseases. We did not adjust for possible higher interdependence between specific combinations of health conditions. In a systematic review of data on older adults with multiple chronic diseases, it was found that the combinations with the highest prevalence rates included hypertension, coronary artery disease and diabetes mellitus [20]. A German study found three multimorbidity patterns through both factor analysis and network analysis: 1) cardiovascular/metabolic disorders, 2) anxiety/depression/somatoform disorders and pain, and 3) neuropsychiatric disorders [23, 24]. In general, there is limited insight into the prevalence of specific disease clusters, especially for combinations of more than two health conditions. Due to this lack of data, the value of the dependence correction factor used in our analyses (1.3) is based on the median reported in the literature. This factor may be lower or higher for certain combinations (e.g. cardiovascular diseases show odds ratios of 5.9 [9]). Sensitivity analyses show a negative linear correlation between the dependence correction factor and the YLD estimates (see Appendix). In our analysis, dependence between health conditions is limited to combinations of two health conditions, since adequate information about the occurrence of more than two health conditions is lacking. This implies that the prevalence of multimorbidity adjusted for dependence between health conditions is underestimated, and that a larger downward YLD adjustment should therefore be applied. In addition to methods for estimating the prevalence of multimorbidity, we explored three different methods for determining the Combined Disability Weight of multimorbidity. The simultaneous occurrence of multiple health conditions may have less impact on a person’s health than might be expected based on the sum of the impacts of the individual health conditions. However, there is no golden standard for estimating Combined Disability Weights. There are specific findings about applying these methods, and an alternative non-parametric method has even been developed. This so-called adjusted decrement estimator method is a variation on the maximum limit method ([11, 13]). However, many studies [13, 25, 26] use utility measures such as EQ-5D scores or Health Utilities Index Mark 3 (HUI3) instead of Disability Weights, resulting in profound differences. Haagsma et al. [12] compared three comorbidity approaches in patients with temporary injury consequences as well as comorbid chronic conditions with non-trivial health impacts. They found that the Disability Weight of injury patients increases proportionally to the number of comorbid health conditions. The Disability Weights in the study by Haagsma et al. were based on EQ-5D scores [12], while in our study the Disability Weights were derived from the Dutch Disability Weights Study [15]. The most effective method in each case depends to a large extent on the available data, and most studies conclude that further research is required to validate the results found [11, 25, 27–30]. This study focuses on accounting for multimorbidity to produce more accurate YLD estimates. However, one could argue that a similar approach may be applied to YLL estimates. Accounting for “multiple causes of death” – i.e. accounting not only for primary causes of death but also for secondary or even tertiary causes – could alter the allocation of YLLs to specific causes of death [31, 32]. Research on this is still in its infancy, however.

Conclusions

Burden of Disease (BoD) calculations that do not account for multimorbidity can result in an overestimation of the real BoD. This may affect public health policy strategies that focus on single health conditions [33]. For instance, cost-effectiveness analyses might overestimate intended effects when focusing on one particular health condition without accounting for multimorbidity. Furthermore, applying the independent prevalence method (Method A) in combination with the multiplicative approach (Method 2) for combining Disability Weights is a preferred approach to account for multimorbidity. This approach to YLD estimates is relatively simple, and may serve as the preferred approach until more insight has been gained into the dependent co-occurrence of health conditions and the consequences of multimorbid conditions in terms of Disability Weight.

Abbreviations

BoD, Burden of Disease; CDW, combined disability weight; COPD, chronic obstructive pulmonary disease; DALY, disability-adjusted life years; DW, disability weight; DWA, disability weight attributable to a particular disease; OR, odds ratio; YLD, years lived with disability; YLL, years of life lost
Table 2

Results in YLDs for all twelve methods, for all 25 health conditions

Independent total-population additiveIndependent total-population multiplicativeIndependent total-population maximum limitDependent total-population additiveDependent total-population multiplicativeDependent total-population maximum limitIndependent, sex-age additiveIndependent, sex-age multiplicativeIndependent, Sex-age maximum limitDependent, sex-age additiveDependent, sex-age multiplicativeDependent, sex-age maximum limit
Anxiety disorders180,000173,000153,000180,000172,000147,000180,000175,000161,000180,000174,000157,000
Coronary heart disease175,000167,000150,000175,000165,000144,000174,000155,000124,000174,000153,000118,000
Diabetes mellitus167,000160,000142,000167,000159,000136,000166,000152,000122,000166,000151,000116,000
Mood disorders164,000155,000143,000164,000153,000139,000164,000156,000146,000164,000154,000143,000
Neck and back pain155,000148,000131,000155,000146,000126,000154,000145,000125,000154,000143,000120,000
Arthrosis124,000120,000107,000124,000119,000104,000123,000114,00092,000123,000113,00088,000
COPD115,000109,00098,000115,000108,00095,000114,000102,00083,000114,000101,00079,000
Stroke115,000107,000103,000115,000106,000100,000113,00097,00088,000113,00095,00085,000
Hearing disorders89,00086,00076,00089,00086,00074,00088,00082,00065,00088,00081,00062,000
Intellectual disabilities56,00052,00048,00056,00052,00047,00056,00053,00050,00056,00053,00049,000
Dementia54,00051,00049,00054,00050,00048,00053,00042,00038,00053,00042,00037,000
Breast cancer47,00045,00040,00047,00045,00038,00047,00042,00034,00047,00042,00032,000
Visual impairments42,00040,00035,00042,00040,00034,00041,00037,00028,00041,00037,00026,000
Asthma38,00037,00033,00038,00037,00032,00038,00037,00034,00038,00037,00033,000
Cardiac arrhythmias30,00029,00025,00030,00029,00024,00030,00027,00020,00030,00027,00019,000
Colon cancer30,00028,00025,00030,00028,00024,00029,00026,00019,00029,00025,00018,000
Personality disorders27,00026,00023,00027,00026,00022,00027,00026,00024,00027,00026,00023,000
Contact Eczema23,00022,00020,00023,00022,00019,00023,00022,00019,00023,00022,00019,000
Heart failure20,00020,00017,00020,00019,00016,00020,00018,00012,00020,00017,00012,000
Prostate cancer19,00018,00016,00019,00018,00015,00019,00016,00012,00019,00016,00011,000
Parkinsons disease15,00014,00013,00015,00013,00012,00014,00012,00010,00014,00012,00010,000
Lung cancer12,00012,00010,00012,00012,00010,00012,00011,0008,00012,00011,0008,000
Valve problems9,0009,0008,0009,0009,0007,0009,0008,0006,0009,0008,0006,000
Non-Hodgkins lymphoma5,0005,0004,0005,0005,0004,0005,0004,0003,0005,0004,0003,000
Skin cancer5,0005,0004,0005,0005,0004,0005,0004,0004,0005,0004,0003,000
Total (25 health conditions)1,717,0001,638,0001,476,0001,717,0001,622,0001,424,0001,705,0001,564,0001,329,0001,705,0001,549,0001,278,000
  30 in total

1.  Disability-adjusted life years: a critical review.

Authors:  S Anand; K Hanson
Journal:  J Health Econ       Date:  1997-12       Impact factor: 3.883

2.  Predicting utility for joint health states: a general framework and a new nonparametric estimator.

Authors:  Alex Z Fu
Journal:  Med Decis Making       Date:  2010-07-19       Impact factor: 2.583

3.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Authors:  Hude Quan; Bing Li; Chantal M Couris; Kiyohide Fushimi; Patrick Graham; Phil Hider; Jean-Marie Januel; Vijaya Sundararajan
Journal:  Am J Epidemiol       Date:  2011-02-17       Impact factor: 4.897

4.  Three methods tested to model SF-6D health utilities for health states involving comorbidity/co-occurring conditions.

Authors:  Janel Hanmer; David Vanness; Ronald Gangnon; Mari Palta; Dennis G Fryback
Journal:  J Clin Epidemiol       Date:  2009-11-06       Impact factor: 6.437

5.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

Authors:  Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie
Journal:  Lancet       Date:  2012-05-10       Impact factor: 79.321

6.  Multimorbidity and comorbidity in the Dutch population - data from general practices.

Authors:  Sandra H van Oostrom; H Susan J Picavet; Boukje M van Gelder; Lidwien C Lemmens; Nancy Hoeymans; Christel E van Dijk; Robert A Verheij; François G Schellevis; Caroline A Baan
Journal:  BMC Public Health       Date:  2012-08-30       Impact factor: 3.295

7.  Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions.

Authors:  Ingmar Schäfer; Eike-Christin von Leitner; Gerhard Schön; Daniela Koller; Heike Hansen; Tina Kolonko; Hanna Kaduszkiewicz; Karl Wegscheider; Gerd Glaeske; Hendrik van den Bussche
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

8.  Disability weights for comorbidity and their influence on health-adjusted life expectancy.

Authors:  Pieter H M van Baal; Nancy Hoeymans; Rudolf T Hoogenveen; G Ardine de Wit; Gert P Westert
Journal:  Popul Health Metr       Date:  2006-04-10

9.  Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints.

Authors:  Brecht Devleesschauwer; Charline Maertens de Noordhout; G Suzanne A Smit; Luc Duchateau; Pierre Dorny; Claudia Stein; Herman Van Oyen; Niko Speybroeck
Journal:  BMC Public Health       Date:  2014-11-21       Impact factor: 3.295

10.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Theo Vos; Abraham D Flaxman; Mohsen Naghavi; Rafael Lozano; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Richard Gosselin; Rebecca Grainger; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jixiang Ma; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  15 in total

1.  The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.

Authors:  Daniela Simões; Fábio Azevedo Araújo; Teresa Monjardino; Milton Severo; Ivo Cruz; Loreto Carmona; Raquel Lucas
Journal:  Rheumatol Int       Date:  2018-02-08       Impact factor: 2.631

2.  Multimorbidity Trends in United States Adults, 1988-2014.

Authors:  Dana E King; Jun Xiang; Courtney S Pilkerton
Journal:  J Am Board Fam Med       Date:  2018 Jul-Aug       Impact factor: 2.657

3.  Dutch DALYs, current and future burden of disease in the Netherlands.

Authors:  Henk B M Hilderink; Marjanne H D Plasmans; M J J C René Poos; Petra E D Eysink; Ronald Gijsen
Journal:  Arch Public Health       Date:  2020-09-22

4.  Towards a needs-based design of the physical rehabilitation workforce in South Africa: trend analysis [1990-2017] and a 5-year forecasting for the most impactful health conditions based on global burden of disease estimates.

Authors:  Q Louw; K Grimmer; K Berner; T Conradie; D T Bedada; T S Jesus
Journal:  BMC Public Health       Date:  2021-05-13       Impact factor: 3.295

5.  Prevalence of metabolic syndrome, discrete or comorbid diabetes and hypertension in sub-Saharan Africa among people living with HIV versus HIV-negative populations: a systematic review and meta-analysis protocol.

Authors:  Olamide O Todowede; Benn Sartorius
Journal:  BMJ Open       Date:  2017-07-09       Impact factor: 2.692

6.  Disability Weights Measurement for 289 Causes of Disease Considering Disease Severity in Korea.

Authors:  Minsu Ock; Bomi Park; Hyesook Park; In-Hwan Oh; Seok-Jun Yoon; Bogeum Cho; Min-Woo Jo
Journal:  J Korean Med Sci       Date:  2019-02-14       Impact factor: 2.153

7.  Reflections on key methodological decisions in national burden of disease assessments.

Authors:  Elena von der Lippe; Brecht Devleesschauwer; Michelle Gourley; Juanita Haagsma; Henk Hilderink; Michael Porst; Annelene Wengler; Grant Wyper; Ian Grant
Journal:  Arch Public Health       Date:  2020-12-31

8.  Recommendations to plan a national burden of disease study.

Authors:  Romana Haneef; Jürgen Schmidt; Anne Gallay; Brecht Devleesschauwer; Ian Grant; Alexander Rommel; Grant Ma Wyper; Herman Van Oyen; Henk Hilderink; Thomas Ziese; John Newton
Journal:  Arch Public Health       Date:  2021-07-07

9.  Adjusting for comorbidity in incidence-based DALY calculations: an individual-based modeling approach.

Authors:  Scott A McDonald; Juanita A Haagsma; Alessandro Cassini; Brecht Devleesschauwer
Journal:  BMC Med Res Methodol       Date:  2020-05-06       Impact factor: 4.615

Review 10.  A framework for indirect elicitation of the public health impact of gambling problems.

Authors:  Matthew Browne; Vijay Rawat; Philip Newall; Stephen Begg; Matthew Rockloff; Nerilee Hing
Journal:  BMC Public Health       Date:  2020-11-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.